Free Alerts   Login
Health Care › Services-Commercial Physical And Biological Research

NOTV Stock Price Correlated With Inotiv Financials

NOTV Stock Price vs. Quarterly
NOTV
Income Statement
Cash Flow
Balance Sheet

NOTV Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

NOTV Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

NOTV Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Leasure Robert Jr.   President and CEO
7,500 sh at $2
$14,864
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group
1,033,314 sh
12,528 sh
1%
$3,792
$648
Balyasny Asset Management
975,295 sh
-221,224 sh
-18%
$3,579
-$106
Millennium Management
252,897 sh
-140,655 sh
-36%
$928
-$284
Blackrock.
216,137 sh
 
$793
Geode Capital Management
192,297 sh
7,562 sh
4%
$706
$137
Wynnefield Capital
150,000 sh
150,000 sh
NEW
$551
$551
OAK FAMILY ADVISORS
146,428 sh
-150 sh
0%
$537
$86
Aqr Capital Management
144,168 sh
-262,628 sh
-65%
$529
-$724
Rice Hall James & Associates
140,749 sh
-11,241 sh
-7%
$517
$49
Ameriprise Financial
111,860 sh
-7,360 sh
-6%
$411
$44
King Luther Capital
98,600 sh
49,300 sh
100%
$362
$210
Squarepoint Ops
92,667 sh
92,667 sh
NEW
$340
$340
Mariner
92,516 sh
92,516 sh
NEW
$340
$340
Marshall Wace,
90,147 sh
69,637 sh
340%
$331
$268
State Street
69,629 sh
7,900 sh
13%
$256
$66
Two Sigma Investments, Lp
54,657 sh
28,853 sh
112%
$201
$122
Fi3 FINANCIAL ADVISORS
47,930 sh
 
$176
XTX Topco
47,722 sh
-10,863 sh
-19%
$175
-$5
Renaissance Technologies
47,464 sh
-7,100 sh
-13%
$0
Susquehanna International Group,
38,804 sh
-696 sh
-2%
$142
$20
COMPANY PROFILE
1.    DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION Inotiv, Inc. and its subsidiaries (“We,” “Our,” “Us,” the “Company,” and “Inotiv”) comprise a leading contract research organization specializing in nonclinical and analytical drug discovery and development services. The Company also manufactures scientific instruments for life sciences research, which it sells with related software for use by pharmaceutical companies, universities, government research centers and medical research institutions. The Company’s customers are located throughout the world. On March 18, 2021, the Company filed Articles of Amendment to the Company’s Second Amended and Restated Articles of Incorporation, as amended, and amended its Second Amended and Restated Bylaws, as amended, to reflect a corporate name change from Bioanalytical Systems, Inc. to Inotiv, Inc.

Free historical financial statements for Inotiv, Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 49 quarters since 2011. Compare with NOTV stock chart to see long term trends.

Data imported from Inotiv, Inc. SEC filings. Check original filings before making any investment decision.